These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 15156483)

  • 1. Financing immunizations in the United States.
    Hinman AR; Orenstein WA; Rodewald L
    Clin Infect Dis; 2004 May; 38(10):1440-6. PubMed ID: 15156483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financing immunization of adults in the United States.
    Orenstein WA; Mootrey GT; Pazol K; Hinman AR
    Clin Pharmacol Ther; 2007 Dec; 82(6):764-8. PubMed ID: 17971821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underinsurance and pediatric immunization delivery in the United States.
    Smith PJ; Molinari NA; Rodewald LE
    Pediatrics; 2009 Dec; 124 Suppl 5():S507-14. PubMed ID: 19948582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of the Medicare influenza vaccination benefit--United States, 1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Oct; 43(42):771-3. PubMed ID: 7935312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary care physician perspectives on reimbursement for childhood immunizations.
    Freed GL; Cowan AE; Clark SJ
    Pediatrics; 2008 Dec; 122(6):1319-24. PubMed ID: 19047252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health insurance and preventive care sources of children at public immunization clinics.
    Lieu TA; Smith MD; Newacheck PW; Langthorn D; Venkatesh P; Herradora R
    Pediatrics; 1994 Mar; 93(3):373-8. PubMed ID: 8115194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing the vaccine financing conundrum.
    Hinman AR
    Health Aff (Millwood); 2005; 24(3):701-4. PubMed ID: 15886163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaps in vaccine financing for underinsured children in the United States.
    Lee GM; Santoli JM; Hannan C; Messonnier ML; Sabin JE; Rusinak D; Gay C; Lett SM; Lieu TA
    JAMA; 2007 Aug; 298(6):638-43. PubMed ID: 17684186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.
    Shen AK; Rodewald LE; Birkhead GS
    Pediatrics; 2009 Dec; 124 Suppl 5():S540-7. PubMed ID: 19948586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare and Medicaid programs; conditions of participation: immunization standards for hospitals, long-term care facilities, and home health agencies. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2002 Oct; 67(191):61808-14. PubMed ID: 12361062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood vaccine finance and safety issues.
    Giffin R; Stratton K; Chalk R
    Health Aff (Millwood); 2004; 23(5):98-111. PubMed ID: 15371374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financing the delivery of vaccines to children and adolescents: challenges to the current system.
    Lindley MC; Shen AK; Orenstein WA; Rodewald LE; Birkhead GS
    Pediatrics; 2009 Dec; 124 Suppl 5():S548-57. PubMed ID: 19948587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicaid program; rescission of the guidelines for documenting Medicaid recipient access to immunizations under the Vaccines for Children (VFC) Program--HCFA. Notice.
    Fed Regist; 1995 Apr; 60(68):18136-7. PubMed ID: 10142043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
    Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult immunization priorities in the United States.
    Lee JS
    Milbank Q; 1996; 74(2):285-307; discussion 309-16. PubMed ID: 8632737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Government financing for health and specific national budget lines: the case of vaccines and immunization.
    Lydon P; Beyai PL; Chaudhri I; Cakmak N; Satoulou A; Dumolard L
    Vaccine; 2008 Dec; 26(51):6727-34. PubMed ID: 18625279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who's calling the shots? Pediatricians' adherence to the 2001-2003 pneumococcal conjugate vaccine-shortage recommendations.
    Broder KR; MacNeil A; Malone S; Schwartz B; Baughman AL; Murphy TV; Pickering LK; Moran JS
    Pediatrics; 2005 Jun; 115(6):1479-87. PubMed ID: 15930207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy.
    Giorgi-Rossi P; Merito M; Borgia P
    Health Policy; 2009 Feb; 89(2):225-38. PubMed ID: 18639952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1148-51. PubMed ID: 18946462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.